A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia - No Study Results Posted

A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia (Borden-001)

This study has been completed.

Study NCT00559091 Information provided by Jewish General Hospital

First Received: November 15, 2007 Last Updated: May 6, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2010
Primary Completion Date:	February 2010 (Final data collection date for primary outcome measure)